TP53 and neoplasm: For example, the double mutation in the order of TP53 and NOTCH, which are representative tumor-suppressor and oncogenes, respectively, was frequently observed in early stage of esophageal carcinoma patients [53], whereas the reverse-ordered mutation is likely to lead to a metastasis progression in mouse experiments [63, 64].